The Xsphera ex vivo platform, invented at the Dana-Farber Cancer Institute, is a powerful integration of biology and cloud computing that accelerates drug development and guides precision medicine. Our proprietary process enables the simultaneous assessment of multiple therapeutics on a single patient-derived tumor specimen.
Unique combination of tumor processing and microfluidics device
Critical to maintaining a complete and viable tumor microenvironment
Validated efficacies for mechanisms of action and mechanisms of resistance
Qualified clinical sites